Infective endocarditis, defined as pathologically or clinically definite by the Duke criteria, was observed in 14 transplant recipients at our institutions. In addition, we reviewed 32 previously reported cases in solid organ transplant recipients. The spectrum of organisms causing infective endocarditis was clearly different in transplant recipients than in the general population; 50% of the infections were due to Aspergillus fumigatus or Staphylococcus aureus, but only 4% were due to viridans streptococci. Fungal infections predominated early (accounting for six of 10 cases of endocarditis within 30 days of transplantation), while bacterial infections caused most cases (80%) after this time. In 80% (37) of the 46 cases in transplant recipients, there was no underlying valvular disease. Seventy-four percent (34) of the 46 cases were associated with previous hospital-acquired infection, notably venous access device and wound infections. Three patients with S. aureus endocarditis had had an episode of S. aureus bacteremia ú3 weeks prior to the diagnosis of endocarditis and had received treatment for the initial bacteremia of õ14 days' duration. The overall mortality rate was 57% (26 of 46 patients died), with 58% (15) of the 26 fatal cases not being suspected during life. Endocarditis is an underappreciated sequela of hospital-acquired infection in transplant recipients.
Infection remains a common cause of morbidity and mortalCenter in Omaha, and the New England Medical Center in Boston were reviewed. ity in recipients of solid organ transplants. Infective endocarditis is rarely described as a complication of transplantation, with A literature review of endocarditis in solid organ transplant recipients was performed by utilizing MEDLINE with the key few cases having been previously reported. Infective endocarditis is increasingly recognized as a nosocomial disease in many words endocarditis and transplantation. Both English-and nonEnglish-language articles were retrieved. The review period inpatients [1] . Transplantation surgery entails multiple invasive procedures and sometimes prolonged hospitalization and is cluded . In addition, the references cited in the retrieved articles were reviewed to discover additional cases. Only well recognized to be associated with bacteremia [2] . A proportion of such patients with bacteremia go on to develop infective cases of endocarditis that met the definition of definite infective endocarditis by the Duke criteria of Durack et al. [3] were included endocarditis. In addition, the immunosuppression necessary for prevention of rejection of transplanted organs predisposes pain the review. Findings or descriptions that were consistent with infective endocarditis but that fell short of the definition of definite tients to invasive fungal infection, particularly with Aspergillus. Although bacteria are widely regarded as the primary cause of infective endocarditis (''possible infective endocarditis'') were rejected, as were infections of intracardiac anastomoses or prosinfective endocarditis in most settings, fungi are a significant cause of this infection in certain populations. thetic material after heart transplantation and cases of viral or toxoplasma endomyocarditis. In this study, we review the etiologic agents, clinical findings, treatment, and outcome of infective endocarditis in solid Fifty-five cases of infective endocarditis in transplant recipients have been reported in the medical literature. Of these cases, 23 organ transplant recipients.
were excluded by our definitions (cytomegalovirus endomyocarditis [4], 1 case; insufficient detail to be defined by the Duke criteria as Methods definite infective endocarditis [5-12], 12 cases; and infections of Cases of endocarditis occurring at the Veterans Affairs Mediintracardiac anastomoses or prosthetic material after heart or heartcal Center in Pittsburgh, the University of Nebraska Medical lung transplantation [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] , 10 cases). Thus, 32 cases of definite infective endocarditis (23 that met the pathological definition and nine that met the clinical criteria for a diagnosis of definite infective NOTE. AmB Å amphotericin B; Amp Å ampicillin; AVR Å aortic valve replacement; Cpfx Å ciprofloxacin; Gm Å gentamicin; HLR Å high-level resistance; MRSA Å methicillin-resistant S. aureus; MVR Å mitral valve replacement; Naf Å nafcillin; Rif Å rifampin; TTE Å transthoracic echocardiography; Vm Å vancomycin; VR Å vancomycin-resistant.
cases of infective endocarditis occurred in 591 patients who
Enterococcus faecalis) were vancomycin-resistant and one (E. faecalis), which exhibited high-level resistance to gentamireceived liver transplants at our institutions. Thus, the prevalence of infective endocarditis in this population was 1.7%.
cin, was vancomycin-susceptible. Two of the three enterococcal isolates were ampicillin-susceptible. All three patients with Of the 14 cases, 7 were due to Staphylococcus aureus, 4 were due to Aspergillus fumigatus, and 3 were due to enterococci.
enterococcal endocarditis survived despite the antibiotic resistance profiles for their isolates. One patient infected with vanOf the enterococcal isolates, two (Enterococcus faecium and / 9c48$$mr47 02-05-98 23:36:47 cidal UC: CID comycin-resistant E. faecium was treated successfully with Three patients underwent transplantation in the precyclosporine era (2 developed aspergillus endocarditis, and 1 early valve replacement and then therapy with vancomycin, ciprofloxacin, and rifampin. Another patient with endocarditis developed S. aureus endocarditis), 34 received cyclosporine therapy (3 developed aspergillus endocarditis, and 31 had infecdue to E. faecalis resistant to vancomycin but susceptible to ampicillin and gentamicin needed desensitization to ampicillin tions due to other organisms), and 9 received tacrolimus therapy (4 developed aspergillus endocarditis, and 5 had infections due because of a history of penicillin allergy; successful treatment of this patient's endocarditis was achieved with a 6-week to other organisms).
Fungal infections tended to predominate as causes of infeccourse of ampicillin and gentamicin. Finally, one patient with a history of penicillin allergy who had endocarditis due to tive endocarditis in the early posttransplantation period, whereas bacteria (especially S. aureus) tended to predominate E. faecalis displaying high-level resistance to gentamicin was successfully treated with a prolonged course of vancomycin later (figure 1). Only one of 14 kidney transplant recipients developed infective endocarditis within the first 8 weeks after alone.
Among these patients, the mortality rate was high (64%; transplantation, compared with nine of 16 liver transplant recipients and nine of 16 heart transplant recipients. Seventy-four nine of 14 patients died). All four cases due to Aspergillus were discovered only at autopsy. Five of seven patients with percent (34) of the 46 cases of infective endocarditis were associated with a presumed hospital-acquired source, and 26% S. aureus endocarditis died.
(12) of the 46 cases were community-acquired ( were left-sided. Right-sided fungal infections affected the triInfective endocarditis occurred in recipients of the following cuspid valve (three cases) and the pulmonary valve (two cases). types of solid organ transplants: liver (16 patients), kidney (13) , Except for one case in which Aspergillus infected the aortic heart (15), heart-lung (1), and kidney-pancreas (1) . No cases valve, the remainder of fungal infections affected the mural have been described in lung or small bowel transplant recipiendocardium rather than the valvular endocardium. ents. The mean age of the patients with infective endocarditis Eighty percent (37) of the 46 patients had no preexisting was 46 years (range, 12 -67 years). Most patients were male valvular disease. Prior to the development of endocarditis, 2 patients had a prosthetic valve, 1 had a bicuspid aortic valve, (35 [76%] of 46). In the early posttransplantation period, infective endocarditis in renal transplant recipients was relatively rare when compared with infective endocarditis in heart and liver transplant recipients. Patients with renal failure treated by dialysis may be less likely to have received intensive interventions that predispose to bacteremia and subsequent endocarditis, such as bronchoscopy, gastrointestinal endoscopy, or surgery and percutaneous liver biopsy [48] . Furthermore, renal transplant recipients can receive therapy to cope with graft rejection (dialysis) and may therefore receive less cumulative immunosuppressive therapy than recipients of other organs. patients with preexisting valvular disease.
Intraabdominal infection 2
Eleven patients (24%) had major embolic phenomena (em- Solid organ transplant recipients with infective endocarditis the patients had been treated with parenteral antistaphylococcal antibiotics for õ14 days (table 4) . Many experts would condiffer from other patients with infective endocarditis in many respects. Although there are limitations in extrapolating data sider that this treatment is suboptimal for staphylococcal bacteremia [50] . Although it is possible that these patients had endofrom previously reported cases (rarer entities are more likely to be reported than those that are seemingly common), fungal carditis originally that relapsed after insufficient treatment of endocarditis, we hypothesize that in these cases suboptimal endocarditis appears to be overrepresented in the transplant population. Fungi were the cause of 28% of cases of infectreatment of staphylococcal bacteremia allowed seeding of the valvular endothelium with subsequent development of endocartive endocarditis in transplant recipients as compared with Ç2% -4% of cases in most series outside the transplant setting ditis. In summary, infections due to Aspergillus and S. aureus [1] . Even in cases of so-called ''nosocomial'' endocarditis, aerobic bacteria predominate, and only 6% of cases of endocaraccounted for 50% of the cases of infective endocarditis in solid organ transplant recipients. A. fumigatus was the most ditis are due to fungi [49] . In contrast, no cases of endocarditis due to viridans streptococci occurred in our institutions, and common cause of infective endocarditis within 30 days after transplantation, and S. aureus was the most frequent pathogen only two cases have been described in transplant recipients; it appears that transplant recipients are not at a significantly after this time. Most of the cases of infective endocarditis were associated with previous hospital-acquired infections, notably higher risk of endocarditis due to viridans streptococci than is the general population. Viridans streptococci are also comparavenous access device and wound infections. Since most cases of endocarditis in transplant recipients occur in patients with tively rare causes of nosocomial endocarditis outside of the transplant setting [49] .
previously normal heart valves and hence may not be readily predicted, prevention and aggressive treatment of hospitalMost (80%) of the solid organ transplant recipients who developed infective endocarditis had no history of valvular acquired infections, particularly bacteremia, in all transplant recipients are of paramount importance. To gain a greater undisease or abnormality. There may be a self-selection effect of organ transplantation for this phenomenon: patients with derstanding of endocarditis in transplant recipients, we recommend that other institutions prospectively evaluate and report significant heart disease may not be considered candidates for transplantation. However, a more likely explanation is that the their experience with this disease process. organism types (e.g., S. aureus and enterococci) causing infective endocarditis in transplant recipients are less likely to need an abnormal valve on which to lodge to produce endocarditis.
